-
remains in that post. In July 2022, the
business announced it
would acquire ViaCyte, Inc. for $320 million. In
April 2024, it was
announced Vertex had agreed...
-
Therapeutics has
established partnerships with
additional companies such as
Viacyte (part of Vertex), Nkarta, Capsida, Curevac, and others.
CRISPR Therapeutics...
-
announces clinical trials for
myopia February 11, 2013 http://
viacyte.com/press-releases/
viacyte-inc-announces-fda-acceptance-of-ind-to-commence-clinical-...
- will
reject the transplant. On
November 17, 2021
CRISPR therapeutics and
ViaCyte announced that the
Canadian medical agency had
approved their request for...
- 2018-11-28. "PEC‐Encap™ (VC-01™)".
Viacyte, Inc.
Archived from the
original on 2019-01-19.
Retrieved 2018-11-29. "Home".
Viacyte, Inc.
Archived from the original...
- company, Bresagen.
After another merger with Novocell, the
company became Viacyte,
which was
acquired by
Vertex in 2022 for its
experience in development...
